NURIX THERAPEUTICS, INC. (NRIX) Free cash flow 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$263.5MFY2025 · since FY2019: -$1.1M → -$263.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$263.5M | -44.9% |
| FY2024 | -$181.9M | -102.6% |
| FY2023 | -$89.8M | +47.8% |
| FY2022 | -$172.1M | -91.1% |
| FY2021 | -$90.0M | -1843.1% |
| FY2020 | -$4.6M | -341.2% |
| FY2019 | -$1.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NRIX financial trends
NRIX RevenueNRIX Net incomeNRIX Net marginNRIX Gross profitNRIX Gross marginNRIX Operating incomeNRIX Operating marginNRIX Operating cash flowNRIX Capital expendituresNRIX Return on equityNRIX Stock buybacksNRIX Dividends paidNRIX Total assetsNRIX Total liabilitiesNRIX Shareholders’ equityNRIX overview →